Elsevier

Addictive Behaviors

Volume 90, March 2019, Pages 369-377
Addictive Behaviors

Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans

https://doi.org/10.1016/j.addbeh.2018.11.032Get rights and content

Highlights

  • Posttraumatic stress disorder (PTSD) is common among individuals with addiction.

  • Rates of PTSD and addiction are particularly high among military veterans.

  • This study tested an integrated treatment for both disorders in military veterans.

  • The treatment included Prolonged Exposure (PE) for PTSD.

  • The treatment was effective and significantly reduced PTSD and substance use severity.

Abstract

Objective

A substantial amount of individuals with substance use disorders (SUD) also meet criteria for posttraumatic stress disorder (PTSD). Prolonged Exposure (PE) is an effective, evidence-based treatment for PTSD, but there is limited data on its use among individuals with current alcohol or drug use disorders. This study evaluated the efficacy of an integrated treatment that incorporates PE (Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure or COPE) among veterans.

Method

Military veterans (N = 81, 90.1% male) with current SUD and PTSD were randomized to 12 sessions of COPE or Relapse Prevention (RP). Primary outcomes included the Clinician Administered PTSD Scale (CAPS), PTSD Checklist-Military version (PCL-M), and the Timeline Follow-back (TLFB).

Results

On average, participants attended 8 out of 12 sessions and there were no group differences in retention. Intent-to-treat analyses revealed that COPE, in comparison to RP, resulted in significantly greater reductions in CAPS (d = 1.4, p < .001) and PCL-M scores (d = 1.3, p = .01), as well as higher rates of PTSD diagnostic remission (OR = 5.3, p < .01). Both groups evidenced significant and comparable reductions in SUD severity during treatment. At 6-months follow-up, participants in COPE evidenced significantly fewer drinks per drinking day than participants in RP (p = .05).

Conclusions

This study is the first to report on the use of an integrated, exposure-based treatment for co-occurring SUD and PTSD in a veteran sample. The findings demonstrate that integrated, exposure-based treatments are feasible and effective for military veterans with SUD and PTSD. Implications for clinical practice are discussed.

Introduction

Substance use disorders (SUD) and posttraumatic stress disorder (PTSD) are two of the most prevalent psychiatric disorders in the United States. In the general population, lifetime estimates are approximately 29.1% for alcohol use disorder, the most common SUD (Grant et al., 2015), and 8.3% for PTSD (Kilpatrick et al., 2013). Among military personnel and veterans, rates of SUD and PTSD are 2–4 times higher than in the general population (Hoge, 2015; Petrakis, Rosenheck, & Desai, 2011; Stein et al., 2017; Teeters, Lancaster, Brown, & Back, 2017).

Research demonstrates high rates of comorbidity between SUD and PTSD. Epidemiologic data indicate that individuals with, as compared to without, an SUD are 6.5 times more likely to have comorbid PTSD (Mills, Teeson, Ross, & Peters, 2006). Comorbid SUD/PTSD is associated with substantial psychiatric comorbidity (e.g., depression), medical problems, vocational impairment, increased violence, and poor treatment outcomes (Barrett, Teeson, & Mills, 2014; Simpson, Lehavot, & Petrakis, 2017; Stein et al., 2017).

Integrated treatments, in which both disorders are addressed concurrently, may help optimize outcomes. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) is an integrated treatment that utilizes Prolonged Exposure (PE; Foa, Hembree, & Rothbaum, 2007) in combination with cognitive behavioral therapy for SUD. Previous studies of COPE among civilians demonstrate efficacy in reducing SUD and PTSD severity (Brady, Dansky, Back, Foa, & Carroll, 2001; Mills et al., 2012; Persson et al., 2017; Ruglass et al., 2017). Despite extensive research demonstrating the ability of PE to significantly reduce PTSD severity (Powers, Halpern, Ferenschak, Gillihan, & Foa, 2010; Resick, Williams, Suvak, Monson, & Gradus, 2012), some clinicians are reluctant to engage in exposure-based trauma work with SUD patients (Norman & Hamblen, 2017) and the vast majority of randomized controlled trials of treatments for PTSD exclude participants with SUD (Leeman et al., 2017). Accumulating evidence demonstrates, however, that PE is safe and associated with significant reductions in SUD severity, even among individuals with complex trauma histories (Foa et al., 2013, Foa et al., 2017; Mills et al., 2012; Norman et al., 2016; Peck, Schumacher, Stasiewicz, & Coffey, 2018; Persson et al., 2017; Ruglass et al., 2017). Further support is provided by recent meta-analyses and critical reviews of the literature demonstrating that exposure-based, integrated treatment results in significant improvements in SUD and PTSD (Roberts, Roberts, Jones, & Bisson, 2015; Simpson et al., 2017).

Given the sustained military operations in Afghanistan and Iraq, and the disproportionately high rates of SUD and PTSD among veterans, the current study addresses a clinically important need by evaluating, for the first time, the efficacy of COPE among military veterans. An active treatment control group was used to control for time and therapeutic attention. We hypothesized that the integrated treatment would reduce self-report and clinician-rated PTSD symptoms, as well as SUD severity (i.e., percent days using and abstinence rates) significantly more than the control group at the end of treatment (session 12).

Section snippets

Participants

Participants were treatment-seeking, U.S. military veterans primarily recruited from newspaper and internet advertisements (e.g., Craigslist). Inclusion criteria included: 1) military veteran, 2) 18–65 years old, 3) met DSM-IV diagnostic criteria for current PTSD and score ≥ 50 on the DSM-IV Clinician Administered PTSD Scale (CAPS; Blake et al., 1995); and 4) met DSM-IV diagnostic criteria for current SUD and endorsed alcohol or drug use in the past 90 days. Exclusion criteria included: 1)

Baseline and clinical characteristics

Participants were mostly male with an average age of 40.4 years (see Table 1). The majority served in Operation Enduring Freedom, Operation Iraqi Freedom or Operation New Dawn (OEF/OIF/OND), with an average of 9.8 years of military service. The average number of trauma types experienced was 8.4 (SD = 2.7) and 81.0% reported a military-related index trauma (see Table 2). The average baseline CAPS score was 79.8, indicating severe to extreme PTSD symptomatology (Weathers et al., 2001). Most

Discussion

This is the first study to evaluate the efficacy of an integrated, exposure-based treatment for co-occurring SUD and PTSD among military veterans. To date, prior studies of integrated treatments for SUD/PTSD, including prior studies of COPE, have focused on non-veteran samples. In this study, the majority of participants were OEF/OIF/OND veterans with military-related traumas. The findings from this study provide critical information to help inform clinical practice guidelines regarding the

Acknowledgement

This work was supported by funding from NIDA grants R01 DA030143 and K02 DA039229, as well as NIAAA grants T32 AA747430 and K23 AA023845.

References (59)

  • D.D. Szafranski et al.

    High rates of PTSD treatment dropout: A possible red herring?

    Journal of Anxiety Disorders

    (2017)
  • D.D. Szafranski et al.

    Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout

    Addictive Behaviors

    (2017)
  • L. Wei et al.

    Properties of the urn randomization in clinical trials

    Controlled Clinical Trials

    (1988)
  • R. Anton et al.

    Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: A randomized controlled trial

    JAMA

    (2006)
  • S. Back et al.

    Concurrent treatment of PTSD and substance use disorders using prolonged exposure (COPE)

  • A.T. Beck et al.

    Manual for the beck depression inventory

    (1996)
  • D. Blake et al.

    The development of a clinician-administered PTSD scale

    Journal of Traumatic Stress

    (1995)
  • S. Coffey et al.

    Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: Revealing mechanisms of alcohol craving in a cue reactivity paradigm

    Psychology of Addictive Behaviors

    (2006)
  • S.F. Coffey et al.

    Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: A randomized controlled trial

    Psychology of Addictive Behaviors

    (2016)
  • Department of Defense (DoD)

    Office of the deputy assistant secretary of defense for military community and family policy

  • L. Dutra et al.

    A meta-analytic review of psychosocial interventions for substance use disorders

    The American Journal of Psychiatry

    (2008)
  • A. Feingold

    Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis

    Psychological Methods

    (2009)
  • E. Foa et al.

    Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial

    Journal of Consulting and Clinical Psychology

    (2017)
  • E. Foa et al.

    Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences therapist guide

    (2007)
  • E. Foa et al.

    Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: A randomized clinical trial

    JAMA

    (2013)
  • B. Grant et al.

    Epidemiology of DSM-5 alcohol use disorder: Results from the National epidemiologic survey on alcohol and related conditions III

    JAMA Psychiatry

    (2015)
  • M. Gray et al.

    Psychometric properties of the life events checklist

    Assessment

    (2004)
  • D. Hien et al.

    Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders

    Journal of Consulting and Clinical Psychology

    (2009)
  • V. Hoffman et al.

    Psychological and pharmacological treatments for adults with postrraumatic stress disoder: A systematic review update

  • Cited by (113)

    View all citing articles on Scopus
    View full text